VERU INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
VERU INC. (VERU) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $2.29 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-10
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $2.29M.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2026-06-30 | $2.29M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 |
| 2025-09-30 | $0.00 10-K · filed 2025-12-17 |
| 2025-06-30 | $136.47K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $585.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $16.94K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $44.94K 10-K · filed 2024-12-16 |
| 2024-06-30 | $76.00K 10-Q · filed 2024-08-08 |
| 2017-09-30 | $4.01M 10-K · filed 2018-01-02 |
| 2017-06-30 | $19.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $11.40K 10-Q · filed 2017-05-10 |
| 2016-03-31 | $54.00K 10-Q · filed 2016-04-28 |
| 2015-12-31 | $16.20K 10-Q · filed 2016-02-02 |
| 2015-09-30 | $27.90K 10-K · filed 2015-12-02 |
| 2015-06-30 | $47.70K 10-Q · filed 2015-07-30 |
| 2015-03-31 | $140.40K 10-Q · filed 2015-04-30 |
| 2014-12-31 | $238.50K 10-Q · filed 2015-02-03 |
| 2014-09-30 | $199.80K 10-K · filed 2014-12-02 |
| 2014-06-30 | $640.20K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $1.23M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $1.41M 10-Q · filed 2014-02-03 |
| 2013-09-30 | $1.73M 10-K · filed 2013-12-03 |
| 2013-06-30 | $1.73M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $1.29M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $1.27M 10-Q · filed 2013-01-30 |
| 2012-09-30 | $1.27M 10-K · filed 2012-12-04 |
| 2012-06-30 | $7.01M 10-Q · filed 2012-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |